FDA DEVICE FACTS
ViperCath XC Peripheral Exchange Catheter
Cardiovascular Systems, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The ViperCath™ XC Peripheral Exchange Catheter is intended to guide and support a guide wire during access of the vasculature, allow for wire exchanges, and provide a conduit for the delivery of saline or diagnostic contrast agents. Cardiovascular Systems, Inc. Special 510(k) Pre-Market Notification for ViperCath XC
Comparison to ViperCath™ XC ViperCath™ XC Predicate: Peripheral Peripheral Exchange Exchange Catheter Catheter K183000 (Subject Device) (Predicate Device) Effective 65, 90, 135, 150 cm 200 cm Length(s) Recommended 5 Fr 5 Fr Guide Catheter Shaft Design Braid-reinforced Braid-reinforced Tip Shape Straight Straight, Angled Maximum Injection 600 psi 600 psi Pressure Guidewire 0.035” 0.035” Compatibility Hydrophilic No No Coating Sterile Yes Yes Single Use Yes Yes Functional and Safety Testing: Dimensional checks and torque to failure testing were performed to verify the modifications are acceptable and meet specifications over the life of the device.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。